Laura Testa Profile
Laura Testa

@LauraTestaMD

Followers
235
Following
413
Statuses
24

Joined May 2019
Don't wanna be here? Send us removal request.
@LauraTestaMD
Laura Testa
5 years
I am happy that reviewer n3 cannot imagine a reality where people need CVCs and there is no ultrasound. Life can be better with more resources. Congratulations to the authors and all our fellow colleagues who battle to deliver the best possible care wherever it is needed.
@MarcioBoniatti
Marcio Boniatti
5 years
Today we received responses from reviewers about an article that investigated a training program for CVC insertion.Reviewers, please be empathetic in the responses. Don't be disrespectful like the reviewer 3. Total ignorance of low-middle income country conditions @dvarvaki
Tweet media one
0
0
6
@LauraTestaMD
Laura Testa
5 years
RT @MedscapePT: ASCO 2020: Resultados dos principais estudos sobre câncer de mama e tumores ginecológicos comentados pelas Dras. Laura Test…
0
2
0
@LauraTestaMD
Laura Testa
5 years
Amazing news from MONARCH E trial. Grateful to all participating!
Tweet media one
0
0
12
@LauraTestaMD
Laura Testa
5 years
@DavidFajgenbaum @ASCO Thank you so much for your inspiring talk! Hope, action, laughter, connection and communication! Stay safe!
0
0
3
@LauraTestaMD
Laura Testa
5 years
RT @paulohoff10: Today we discharged home a 97 year old woman who had been admitted to our hospital with a severe COVID infection. Best Eas…
0
32
0
@LauraTestaMD
Laura Testa
5 years
RT @laurojardim: Mais 100 UTIs para o coronavírus no Rio | Lauro Jardim - O Globo
0
5
0
@LauraTestaMD
Laura Testa
5 years
RT @MedscapePT: Inibidores da PARP dominaram as novidades em tumores ginecológicos da #ESMO19, assista ao vídeo com um resumo do que foi ap…
0
1
0
@LauraTestaMD
Laura Testa
5 years
Great to be around my Cardio Onc friends talking about exercise! Impressive meeting, congratulations to all the organizers!
@carolinasilvaMD
Carolina Silva, MD, PhD
5 years
Excellent talk at #GCOS2019 by my dear friend @LauraTestaMD on the role of exercise on cancer patients. Congrats 👏👏👏👏👏👏👏👏👏
Tweet media one
Tweet media two
0
0
9
@LauraTestaMD
Laura Testa
5 years
RT @pires_veridiana: Our 10 year follow up of 100 adult osteossarcomas treated with cis -dox without MTX. 5Y OS 67.3%
0
2
0
@LauraTestaMD
Laura Testa
5 years
RT @MedscapePT: A @LauraTestaMD acaba de gravar com o @GilbertoAmorim6 sobre o melhor em câncer de mama na #ESMO19. Acompanhe a nossa cober…
0
1
0
@LauraTestaMD
Laura Testa
5 years
RT @GilbertodeCas13: ICESP team at ESMO2019: many presentations and authorships! Very proud to be part of it! #icesp #ESMO2019 https://t.co…
0
3
0
@LauraTestaMD
Laura Testa
5 years
@CarolCardioOnc Welcome back ❤
0
0
1
@LauraTestaMD
Laura Testa
5 years
RT @DrSGraff: Our Accomplice Guide — For the Breast of Us #bcsm
0
7
0
@LauraTestaMD
Laura Testa
6 years
@itsnot_pink I usually already know trials open in my institution. And I look for trials in and outside my workplace every time we start a new treatment, even if there is a good standard of care option.
0
1
5
@LauraTestaMD
Laura Testa
6 years
RT @FAndreMD: we are looking for 2 highly motivated MDPhD to develop clin research and AI-based molecular predictors in the precision medic…
0
61
0
@LauraTestaMD
Laura Testa
6 years
@f_g_zampieri Very interesting point really, although I want my boss to stick around for at least 20 more...
0
0
0
@LauraTestaMD
Laura Testa
6 years
@itsnot_pink There you go
Tweet media one
1
0
0
@LauraTestaMD
Laura Testa
6 years
@itsnot_pink Julia, patients with other germline mutations such as RAD51c might be responders to PARP inhibition. Unfortunately there is no hint yet that somatic mutations will be good biomarkers for PARPi response. Excluding HER2+ patients is actually a matter of simplifying study design...
1
0
1